Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-77,075
Closed -$112K 6870
2025
Q3
$112K Sell
77,075
-68,763
-47% -$126K ﹤0.01% 6062
2025
Q2
$376K Sell
145,838
-24,880
-15% -$56.3K ﹤0.01% 5327
2025
Q1
$376K Buy
170,718
+92,463
+118% +$603K ﹤0.01% 5359
2024
Q4
$627K Buy
78,255
+14,680
+23% +$121K ﹤0.01% 5113
2024
Q3
$519K Sell
63,575
-19,037
-23% -$161K ﹤0.01% 5033
2024
Q2
$770K Sell
82,612
-219
-0.3% -$2.33K ﹤0.01% 4584
2024
Q1
$1.02M Sell
82,831
-59,404
-42% -$713K ﹤0.01% 4333
2023
Q4
$1.55M Buy
142,235
+37,003
+35% +$329K ﹤0.01% 4110
2023
Q3
$842K Sell
105,232
-16,481
-14% -$138K ﹤0.01% 4385
2023
Q2
$1.17M Buy
121,713
+47,221
+63% +$490K ﹤0.01% 4243
2023
Q1
$894K Buy
74,492
+18,604
+33% +$243K ﹤0.01% 4455
2022
Q4
$777K Sell
55,888
-82,250
-60% -$994K ﹤0.01% 4588
2022
Q3
$1.25M Sell
138,138
-99,614
-42% -$871K ﹤0.01% 4356
2022
Q2
$1.9M Sell
237,752
-122,464
-34% -$867K ﹤0.01% 4104
2022
Q1
$2.24M Sell
360,216
-240,340
-40% -$1.69M ﹤0.01% 4159
2021
Q4
$5.44M Buy
600,556
+570,820
+1,920% +$6.33M ﹤0.01% 3323
2021
Q3
$307K Sell
29,736
-16,481
-36% -$212K ﹤0.01% 5483
2021
Q2
$653K Buy
46,217
+33,328
+259% +$461K ﹤0.01% 5055
2021
Q1
$179K Sell
12,889
-267,214
-95% -$4.08M ﹤0.01% 5682
2020
Q4
$3.43M Buy
280,103
+22,725
+9% +$296K ﹤0.01% 3303
2020
Q3
$4.08M Buy
257,378
+210,497
+449% +$3.55M ﹤0.01% 3057
2020
Q2
$1.06M Buy
46,881
+35,305
+305% +$591K ﹤0.01% 3902
2020
Q1
$117K Sell
11,576
-59,075
-84% -$575K ﹤0.01% 4905
2019
Q4
$505K Buy
+70,651
New +$621K ﹤0.01% 4503
2019
Q3
Sell
-155,013
Closed -$1.27M 5414
2019
Q2
$1.27M Buy
+155,013
New +$1.01M ﹤0.01% 3824

Other funds holding ZYXI

Goldman Sachs's ZYXI Position: Q4 2025 in Review

Goldman Sachs sold out of Zynex (ZYXI) in Q4 2025, closing a stake of 77,075 shares — an estimated $112K sold.

Goldman Sachs first reported a position in ZYXI in Q2 2019 and held it in 25 quarters. The position peaked at $5.44M in Q4 2021. 5 funds tracked by Wall St. Rank hold ZYXI as of Q4 2025.

  • Goldman Sachs reported no remaining Zynex position as of Q4 2025 after selling out during the quarter.
  • Goldman Sachs sold 77,075 Zynex shares in Q4 2025, an estimated $112K.
  • Goldman Sachs first reported a position in Zynex in Q2 2019 and held it in 25 quarters.
  • Goldman Sachs's Zynex position peaked at $5.44M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Zynex as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.